Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • DrDTonge
    Member
    • May 2011
    • 23

    #1

    Normalisation

    Dear all,

    Apologies if this is a naive question however I'm just wondering at what stage people implement normalisation steps into their library preparation.

    As a bit of background, I have 30 samples which I wish to run small RNA sequencing (my interest is miRNAs) and then compare the relative expression of these.

    Do people start each reaction with the same quantity of small RNA (as determined by the small RNA chip) and then control for cDNA yield OR input a fixed volume of RNA and then control for cDNA yield?

    I would always usually control at every single stage, however, some samples have much lower small RNA concs so I don't want to risk inputting the lowest amount and risk the libraries failling.

    Your help would be much appreciated,

    D
  • DrDTonge
    Member
    • May 2011
    • 23

    #2
    Sorry guys...any thoughts?

    Comment

    • pbluescript
      Senior Member
      • Nov 2009
      • 224

      #3
      I don't do small RNA sequencing, but generally, I do put in the same amount of input. However, as the actual sequencing requires such a tiny amount of library, you usually just sample a small aliquot from your finished library. If you are worried about some libraries failing, then I would start with more.

      Comment

      • DrDTonge
        Member
        • May 2011
        • 23

        #4
        Thanks for your response.

        Given the large variation between samples (this is expected as they are from different disease stages) I am going to start with a standard volume of RNA (3ul) and then normalise by adding a fixed concentration of cDNA library into the sequencing reaction.

        Best wishes,

        D

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 11:13 AM
        0 responses
        19 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, Yesterday, 10:48 AM
        0 responses
        18 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-15-2026, 10:52 AM
        0 responses
        36 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        42 views
        0 reactions
        Last Post SEQadmin2  
        Working...